Combination of baseline total metabolic tumor volume measured on FDG‐PET / CT and β2‐microglobulin have a robust predictive value in patients with primary breast lymphoma-Reference-Cited by-同舟云学术

Combination of baseline total metabolic tumor volume measured on FDG‐PET / CT and β2‐microglobulin have a robust predictive value in patients with primary breast lymphoma

Published:2020-07-30 Issue:4 Volume:38 Page:493-500
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Zhao Peiqi¹^ORCID,Zhu Lei²,Song Zheng¹,Wang Xianhuo¹,Ma Wenchao²,Zhu Xiang²,Qiu Lihua¹,Li Lanfang¹,Zhou Shiyong¹,Qian Zhengzi¹,Xu Wengui²,Zhang Huilai¹

Affiliation:

1. Department of Lymphoma, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University Tianjin P.R. China

2. Department of Molecular Imaging and Nuclear Medicine, National Clinical Research Center for Cancer Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University Tianjin P.R. China

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2763

Reference45 articles.

1. Primary breast lymphoma

2. Primary Lymphoma of the Breast

3. Bilateral Primary Breast Lymphoma

4. Lymphomas of the breast

5. Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment of a prognosis prediction model for lung squamous cell carcinoma related to PET/CT: basing on immunogenic cell death-related lncRNA;BMC Pulmonary Medicine;2023-12-15

2. The prognostic value of IPI in patients with primary breast lymphoma, a multicenter retrospective study;Cancer Cell International;2022-11-15

3. A modified prognostic model in patients with diffuse large B‑cell lymphoma treated with immunochemotherapy;Oncology Letters;2021-01-20